Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes~* Currently treated with insulin~* Currently treated with Metformin~* HbA1c: 7.5-12.0%~Exclusion Criteria:~* Body Mass Index (BMI) \< 25.0 or \> 40.0 kg/m2~* Metformin contraindications according to local practice~* TZDs within 6 months prior to randomisation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).